Why Pharma Must Change Its Model

A difficult feat to accomplish in business is to make dramatic change in the midst of current success. History is littered with companies that were once on top of the world and today are non-existent or merely footnotes because they were unable to make sustainable changes when times were good and yet change was required.

Last week, the Food and Drug Administration approved the first in a new class of drugs intended to treat high cholesterol, called PCSK9 inhibitors. Many experts are predicting it will prove to be the most expensive class of drugs ever. The companies developing these new products stand to make billions of dollars.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news